Maternal Blood Pressure in Relation to Prenatal Lipid-Based Nutrient Supplementation and Adverse Birth Outcomes in a Ghanaian Cohort: A Randomized Controlled Trial and Cohort Analysis.
Alyssa M AbreuRebecca R YoungAshley L BuchananIngrid E LofgrenHarriet E T OkronipaAnna LarteyPer AshornSeth Adu-AfarwuahKathryn G DeweyBrietta M OaksPublished in: The Journal of nutrition (2022)
Daily provision of LNSs does not affect maternal hypertension, compared with IFA and MMN. Higher SBP and DBP are associated with a shorter gestation and smaller birth size; however, only high DBP is associated with LBW and PTB. The new BP cutoffs may help identify pregnancies at risk of adverse birth outcomes.This trial was registered at clinicaltrials.gov as NCT00970866.
Keyphrases
- gestational age
- birth weight
- blood pressure
- pregnancy outcomes
- preterm birth
- pregnant women
- clinical trial
- hypertensive patients
- preterm infants
- physical activity
- heart rate
- randomized controlled trial
- emergency department
- adverse drug
- phase iii
- phase ii
- skeletal muscle
- metabolic syndrome
- open label
- insulin resistance
- body mass index